JNJ-56022473

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-56022473, covering 2017-11-27 to 2017-11-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus [Phase 1]

See pricing